Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$78M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$51.4M |
| 3 |
Alibaba
BABA
|
+$48.4M |
| 4 |
PG&E
PCG
|
+$38.2M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$32.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$27.8M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$22.4M |
| 3 |
McKesson
MCK
|
+$18.1M |
| 4 |
DraftKings
DKNG
|
+$15.1M |
| 5 |
Mastercard
MA
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.36% |
| 2 | Healthcare | 10.23% |
| 3 | Industrials | 9.8% |
| 4 | Financials | 9.25% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PS
651
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $1.2M | 0.03% |
+66,426
| New | +$1.12M |
|
652
ImmunityBio
IBRX
$8.26B
| $1.2M | 0.03% |
97,471
+15,850
| +19% | +$89.5K |
|
653
East-West Bancorp
EWBC
$17.8B
| $1.2M | 0.03% |
+32,975
| New | +$1.1M |
|
654
Loews
L
$22.5B
| $1.19M | 0.03% |
34,755
+13,934
| +67% | +$470K |
|
655
Molina Healthcare
MOH
$10.5B
| $1.19M | 0.03% |
6,697
+2,086
| +45% | +$355K |
|
|
DEA
656
Easterly Government Properties
DEA
$1.16B
| $1.19M | 0.03% |
+20,608
| New | +$1.31M |
|
|
OPLN
657
Openlane
OPLN
$4.08B
| $1.19M | 0.03% |
+86,424
| New | +$1.19M |
|
658
Huntsman Corp
HUN
$1.75B
| $1.19M | 0.03% |
+65,916
| New | +$1.11M |
|
659
MDU Resources
MDU
$4.2B
| $1.18M | 0.03% |
139,873
+99,207
| +244% | +$824K |
|
|
HOME
660
DELISTED
At Home Group Inc.
HOME
| $1.18M | 0.03% |
181,653
+167,440
| +1,178% | +$685K |
|
661
CubeSmart
CUBE
$9.21B
| $1.18M | 0.03% |
+43,657
| New | +$1.15M |
|
|
SIVB
662
DELISTED
SVB Financial Group
SIVB
| $1.18M | 0.03% |
+5,452
| New | +$1.05M |
|
663
Innovative Industrial Properties
IIPR
$1.56B
| $1.17M | 0.03% |
+13,341
| New | +$1.09M |
|
664
Masco
MAS
$14.5B
| $1.17M | 0.03% |
23,301
+7,348
| +46% | +$319K |
|
665
Nasdaq
NDAQ
$54.9B
| $1.17M | 0.03% |
29,367
+9,501
| +48% | +$354K |
|
|
VIVO
666
DELISTED
Meridian Bioscience Inc
VIVO
| $1.17M | 0.03% |
50,071
+35,872
| +253% | +$520K |
|
667
DaVita
DVA
$11.1B
| $1.17M | 0.03% |
14,723
+10,284
| +232% | +$803K |
|
668
Gen Digital
GEN
$17.3B
| $1.16M | 0.03% |
58,595
+48,037
| +455% | +$978K |
|
|
HEES
669
DELISTED
H&E Equipment Services
HEES
| $1.16M | 0.03% |
+62,788
| New | +$999K |
|
|
DCOM
670
DELISTED
Dime Community Bancshares
DCOM
| $1.16M | 0.03% |
+84,522
| New | +$1.22M |
|
671
Amphenol
APH
$194B
| $1.16M | 0.03% |
48,344
-70,328
| -59% | -$1.57M |
|
672
Credicorp
BAP
$30.1B
| $1.15M | 0.03% |
+8,634
| New | +$1.23M |
|
673
Kforce
KFRC
$1.05B
| $1.15M | 0.03% |
+39,325
| New | +$1.14M |
|
674
National Health Investors
NHI
$3.6B
| $1.15M | 0.03% |
+18,854
| New | +$1.04M |
|
675
Encore Capital Group
ECPG
$2.15B
| $1.14M | 0.03% |
+33,346
| New | +$993K |
|
Similar funds
Michael Gelband's Q2 2020 Portfolio in Review
As of Q2 2020, Michael Gelband held 2,172 positions worth $3.85B, up 111% from $1.82B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Michael Gelband deployed $1.66B of net new capital in Q2 2020, opening 1,142 new positions and adding to 418 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Amazon, an estimated $27.8M trimmed.
- Michael Gelband's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.
- Michael Gelband added most to PG&E in Q2 2020, an estimated $38.2M increase.
- Michael Gelband's biggest Q2 2020 reduction was Amazon, cutting an estimated $27.8M.
- Michael Gelband fully exited McKesson in Q2 2020, selling an estimated $18.1M.
- Michael Gelband's ten largest holdings make up 17% of its $3.85B portfolio in Q2 2020.
- Michael Gelband opened 1,142 new positions and closed 448 in Q2 2020.
- Michael Gelband's portfolio value rose 111% quarter-over-quarter to $3.85B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.